Ars TechnicaEarly tests of vaccine for COVID-19 pass peer review, look promisingMay 26, 2020more_vert
STATModerna executives have cashed out $89M in shares this year, as stock price has soared on vaccine hopesMay 27, 2020Damian GardeBy Damian Gardemore_vert